SS3 CRISPR-Cas9 Technology

Program: Special Scientific Session
Basic Session
Sunday, April 3, 2016: 3:30 PM-4:15 PM
Room 153 (BCEC)
Speaker:
John Doench, PhD, Broad Institute of MIT and Harvard, Cambridge,

Nothing to Disclose: JD

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire